US5310876AExpiredUtility

Expression of HIV1 and HIV2 polypeptides and their use

55
Assignee: BOEHRINGER MANNHEIM GMBHPriority: Jan 30, 1990Filed: Jan 25, 1991Granted: May 10, 1994
Est. expiryJan 30, 2010(expired)· nominal 20-yr term from priority
C07K 14/005C12N 15/62C12N 2740/16222C07K 2319/40G01N 33/56988G01N 33/535C12N 2740/16122C07K 2319/735G01N 33/543C07K 2319/00
55
PatentIndex Score
13
Cited by
12
References
4
Claims

Abstract

A fusion protein with at least one antigenic and/or immunogenic determinant from the env, gag and/or pol region of HIV1 and/or HIV2 which contains the tetrapeptide sequence NH 2 -Met-Tyr-Tyr-Leu as the N-terminal component as well as a process for its production and use.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A fusion protein, comprising at least one antigenic or immunogenic determinant from a protein coded for by an HIV2 env region and having the amino acid sequence set forth in SEQ ID NO: 4, fused to a polypeptide not having an antigenic or immunogenic determinant, said polypeptide consisting essentially of an N-terminal sequence --NH 2  --Met--Tyr--Leu.   
     
     
       2. A fusion protein, comprising at least one antigenic or immunogenic determinant from a protein coded for by an HIV1 pol region and an HIV2 env region and having the amino acid sequence set forth in SEQ ID NO: 6, fused to a polypeptide not having an antigenic or immunogenic determinant, said polypeptide consisting essentially of an N-terminal sequence --NH 2  --Met--Tyr--Tyr--Leu.   
     
     
       3. A fusion protein, comprising at least one antigenic or immunogenic determinant from a protein coded for by an HIV2 env region, an HIV1 pol region, an HIV1 env region and an HIV1 gag region and having the amino acid sequence set forth in SEQ ID NO: 7, fused to a polypeptide not having an antigenic or immunogenic determinant, said polypeptide consisting essentially of an N-terminal sequence --NH 2  --Met--Tyr--Tyr--Leu.   
     
     
       4. A fusion protein, comprising at least one antigenic or immunogenic determinant from a protein coded for by an HIV2 env region, an HIV1 pol region, an HIV1 env region, an HIV1gag region, poly(Lys,Arg)n as a C-terminal amino acid sequence, and the amino acid sequence set forth in SEQ ID NO: 8, fused to a polypeptide not having an antigenic or immunogenic determinant, said polypeptide consisting essentially of an N-terminal sequence --NH 2  --Met--Tyr--Tyr--Leu.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.